These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Perinatal morbidity and mortality in pregnancy hypertensive disorders: prognostic value of the clinical and laboratory findings. Acién P, Lloret G, Lloret M. Int J Gynaecol Obstet; 1990 Jul; 32(3):229-35. PubMed ID: 1972114 [Abstract] [Full Text] [Related]
25. Hypertension and its relation to renal function 10 years after pregnancy complicated by pre-eclampsia and pregnancy induced hypertension. Shammas AG, Maayah JF. Saudi Med J; 2000 Feb; 21(2):190-2. PubMed ID: 11533780 [Abstract] [Full Text] [Related]
26. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gul A, Cebeci A, Aslan H, Polat I, Ozdemir A, Ceylan Y. Gynecol Obstet Invest; 2005 Feb; 59(2):113-8. PubMed ID: 15591806 [Abstract] [Full Text] [Related]
27. Prevalence of cesarean delivery in preeclamptic patients with elevated uric acid. Gowri V, Al-Zakwani I. Hypertens Pregnancy; 2010 Jan; 29(2):231-5. PubMed ID: 20367508 [Abstract] [Full Text] [Related]
28. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies. Wu Y, Xiong X, Fraser WD, Luo ZC. Am J Hypertens; 2012 Jun; 25(6):711-7. PubMed ID: 22378034 [Abstract] [Full Text] [Related]
29. Preeclampsia into eclampsia: toward a new paradigm. Katz VL, Farmer R, Kuller JA. Am J Obstet Gynecol; 2000 Jun; 182(6):1389-96. PubMed ID: 10871454 [Abstract] [Full Text] [Related]
30. Serum albumin, creatinine, uric acid and hypertensive disorders of pregnancy. Salako BL, Odukogbe AT, Olayemi O, Adedapo KS, Aimakhu CO, Alu FE, Ola B. East Afr Med J; 2003 Aug; 80(8):424-8. PubMed ID: 14601785 [Abstract] [Full Text] [Related]
34. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography. Baweja S, Kent A, Masterson R, Roberts S, McMahon LP. BJOG; 2011 Aug; 118(9):1126-32. PubMed ID: 21481153 [Abstract] [Full Text] [Related]
35. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. Elhassan EM, Mirghani OA, Habour AB, Adam I. East Afr Med J; 2002 Apr; 79(4):172-5. PubMed ID: 12625668 [Abstract] [Full Text] [Related]
37. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery? Chammas MF, Nguyen TM, Li MA, Nuwayhid BS, Castro LC. Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325 [Abstract] [Full Text] [Related]
38. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies. Thornton CE, Makris A, Ogle RF, Tooher JM, Hennessy A. Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):466-70. PubMed ID: 19930427 [Abstract] [Full Text] [Related]
39. Anaesthetic management of patients with pre-eclampsia/eclampsia and perinatal outcome. Okafor UV, Efetie ER, Igwe W, Okezie O. J Matern Fetal Neonatal Med; 2009 Aug; 22(8):688-92. PubMed ID: 19504406 [Abstract] [Full Text] [Related]
40. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation. Laskowska M, Laskowska K, Leszczyńska-Gorzelak B, Oleszczuk J. Gynecol Obstet Invest; 2007 Aug; 64(1):8-13. PubMed ID: 17199090 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]